Inside an unassuming yet sprawling industrial building nestled within the high plains of Watkins, about a 30-minute drive southeast of Denver International Airport, step into Kazmira Therapeutics’ ...

When a medication doesn’t exist in the right dose, form or formulation, patients are left with few options – a challenge in rural areas like La Plata County. That gap is filled by compounding ...

Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding ...

Legislative sessions are underway in most states, and some have introduced novel legislation to regulate compounded ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

More than a decade after the Drug Quality and Security Act (DQSA) of 2013 created the 503B category, the central question ...

TogetherIV is the brain child of two Edina High School students, including one who gets monthly treatments for chronic ...

WASHINGTON, Jan 15 (Reuters) - Drugmakers Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new tab have been sued in Texas by a compounding pharmacy that alleges they are illegally ...

The MarketWatch News Department was not involved in the creation of this content. Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient ...

Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...